refillable injection pen for semaglutide 60 Unit Reusable Research Injector with Protect Case and 2Pcs 3ml Cartridges (Blue) : Health & Household Wegovy® GLP-1 Semaglutide Injections -

A pooled post hoc analysis of the SURPASS-1 through SURPASS-5 clinical trials published in Diabetes Care found that tirzepatide was associated with significant reductions in albuminuria, a key marker of kidney damage

In clinical trials, 7%--13% of people taking Wegovy experienced burping

Identification of the active-site serine in human pancreatic lipase by chemical modification with tetrahydrolipstatin

This new weight loss drug, expected to be available before 2030, offers a promising option for those seeking effective weight management solutions

As advancements continue in the field, innovations in surgical techniques and a collaborative approach are enhancing patient outcomes, establishing bariatric surgery as a viable option for those seeking lasting weight loss solutions

Analyzing the individual components of MACE, the use of arGLP-1 reduced the risk of cardiovascular death (HR 0.87, 95% CI: 0.800.94